Fas Role in Ischemic Stroke; Not Only in Apoptosis
a ular nd G ec en l e o t i M c f M Sergeeva et al., J Mol Genet Med 2016, 10:4 o l e d Journal of Molecular and Genetic a i n c r DOI: 10.4172/1747-0862.1000236 i n u e o J ISSN: 1747-0862 Medicine ReviewResearch Article Article Open Access Fas Role in Ischemic Stroke: Not Only in Apoptosis Sergeeva SP1, Gorbacheva LR2,3*, Breslavich ID4 and Cherdak MA5 1Department of Pathophysiology, I.M Sechenov First Moscow State Medical University, Trubetskaya Street, 8-2, Moscow, Russia 2Department of Physiology, Pirogov Russian National Research Medical University, Ostrovitianov Street, 1, Moscow, Russia 3Department of Physiology, Lomonosov Moscow State University, Leninskiye Gory, 1, Moscow, Russia 4Faculty of Mechanics and Mathematics, Lomonosov Moscow State University, GSP-1, 1 Leninskiye Gory, 1, Moscow, Russia 5Department of Neurological Diseases, I.M. Sechenov First Moscow State Medical University, Trubetskaya street, Moscow, Russia Abstract The receptors, whose ligand interaction activation was previously considered to be associated with initiation of apoptosis only, can have a range of biological effects: apoptosis, inflammation, proliferation, and differentiation. Therefore, interaction between death receptor and its ligand does not always mean the initiation of programmed cell death and blocking of this ligand-receptor interaction can affect the initiation of recovery and neuroplasticity mechanisms. Fas is one of these death receptors. The following review represents data on the conditions of Fas- dependent signal pathways induction in ischemic stroke. There is a possibility for the development of new target neuroprotective drugs with selective effects on different separated signal pathways, activated by ligand-receptor interactions in Fas-FasL (Fas ligand) system.
[Show full text]